SCHEMBL7651725

SCHEMBL7651725

Nc1ccc(Oc2c(F)c(F)nc(Oc3ccc(C(=O)O)cc3)c2F)cc1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
F10 P00742 3/20 0.39
AMY1A P0DUB6 1/20 0.39
PARP15 Q460N3 1/20 0.37
PARP10 Q53GL7 1/20 0.37
PTGER4 P35408 4/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
FEN1 P39748 2/20 0.36
ALOX5AP P20292 1/20 0.36
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
RXRG P48443 1/20 0.36
LMNA P02545 1/20 0.35
F2 P00734 1/20 0.35
BTK Q06187 1/20 0.34
LOXL2 Q9Y4K0 1/20 0.34
SRD5A2 P31213 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8374926 0.90 MMP2 (0.41) HPGDHTTF10AMY1APTGER4
SCHEMBL8374929 0.89 FEN1 (0.36) HPGDHTTF10AMY1APTGER4
SCHEMBL4623895 0.89 F10 (0.38) HPGDF10KDM4ELMNAF2
SCHEMBL7658168 0.83 HPGD (0.50) HPGDHTTAMY1APARP15PARP10
SCHEMBL7654088 0.78 PARP10 (0.58) PARP15PARP10KDM4EALDH1A1RXRA
SCHEMBL7656090 0.77 HTT (0.44) HPGDHTTAMY1APARP15PARP10
SCHEMBL8372872 0.74 MMP2 (0.41) HPGDHTTF10PARP15PARP10
SCHEMBL7714315 0.74 MAPT (0.50) HPGDHTTKDM4EALDH1A1SMN1; SMN2
SCHEMBL8372873 0.73 KDM4E (0.35) HPGDHTTF10PARP10PTGER4
SCHEMBL24407671 0.71 HPGD (0.63) HPGDHTTPARP15PARP10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0905170-B1 Polybenzoxazoles and polybenzothiazoles precursors QIMONDA AG (DE) 2013-10-30 EP disclosed
US-6437178-B2 REACTING A HALOGENATED BENZENE COMPOUND WITH NITRO(THIO)PHENOL; REDUCTION INFINEON TECHNOLOGIES AG (DE) 2002-08-20 US disclosed
US-20010056203-A1 O-aminophenolcarboxylic acid and o-aminothiophenolcarboxylic acid SIEMENS AKTIENGESELLSCHAFT 2001-12-27 US disclosed
EP-0905123-B1 o-amino(thio)phenol-carboxylic acids and their preparation INFINEON TECHNOLOGIES AG (DE) 2001-12-12 EP disclosed
US-6310238-B1 INTERMEDIATES FOR THE PREPARATION OF POLYBENZOXAZOLES AND POLYBENZOTHIAZOLES SIEMENS AKTIENGESELLSCHAFT (DE) 2001-10-30 US disclosed
EP-0905123-A1 o-amino(thio)phenol-carboxylic acids and their preparation SIEMENS AKTIENGESELLSCHAFT (DE) 1999-03-31 EP disclosed
EP-0905170-A2 Polybenzoxazoles and polybenzothiazoles precursors SIEMENS AKTIENGESELLSCHAFT (DE) 1999-03-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010056203-A1 O-aminophenolcarboxylic acid and o-aminothiophenolcarboxylic acid TPMT, PAH, AADAT HPGD 1718/4885HTT 2766/4885F10 3604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.